Thryve funding news – Berlin-Based Thryve Raises €4 Million in Series A Round Funding
Aug 30, 2024 | By Team SR
Thryve, a B2B health data integration and analytics company, raises €4 million in sseries A round funding. The company's aspirational aspirations for international expansion will be bolstered by this substantial investment, which will also improve its wearable integration capabilities for automated prevention and treatment.
SUMMARY
- Thryve, a B2B health data integration and analytics company, raises €4 million in sseries A round funding.
- Thryve gives healthcare companies access to people's data and offers useful insights into their health.
Capricorn Partners, based in Belgium, led the fundraising round. IBB Ventures, CRB Health Tech, based in Spain, and the German Carma Fund also provided support.
Health providers throughout the globe are now able to continuously monitor and understand a person's health state using data gathered from hundreds of health trackers thanks to it's unified API, which is at the forefront of health data integration. This technology is essential to the provision of automated, preventative care that is available anytime, anyplace.
RECOMMENDED FOR YOU
[Funding alert] Berlin-based Urban Sports Club Raises €95 Million in Funding
Team SR
Dec 15, 2023
Over 50 million people in Europe have already accessed Thryve's early prevention solutions through their health insurance, demonstrating the widespread adoption of its technology. Thryve's technology is used by major players including Sanitas in Spain and AOK in Germany. Thryve's data integration is used by digital therapeutics, such the industry-leading DiGA-certified Sidekick Rx, to improve proactive care and individualization, especially when treating obesity with its product Zanadio.
The need for healthcare far outstrips supply as developed countries struggle with an aging population and a declining labor force. The pressure on the healthcare system will only increase as more than thirty percent of doctors in Germany plan to retire in the next five years.
Digital health services are gaining popularity among payers, customers, and regulators because they offer quicker and more proactive care. With one in two people currently using a health tracker and the industry expanding by more than 20% yearly, Thryve's technology is essential for both preventing sickness through early diagnosis and guaranteeing ongoing access to relevant healthcare insights.
Antoine D´Hollander, Investment Director at Capricorn Partners, commented on the investment: “This new funding aligns with our strategy to utilize real-world data for personalized prevention and therapeutics. We are excited about Thryve’s solution, which creates a cost-efficient healthcare ecosystem by integrating data from numerous wearable devices and health apps, facilitating tailored interventions and effective monitoring.”
Thryve’s CEO, Friedrich Lammel, echoed this enthusiasm: “Healthcare is undergoing an epochal transition. I’m convinced that our engine will help the industry make millions of doctor’s visits obsolete and add 20 healthy years to individuals’ lives in the next five years. We’re excited to partner with leading European health funds on this mission and look forward to accelerating our growth.”
About Thryve
Thryve gives healthcare companies access to people's data and offers useful insights into their health. Through the provision of health-related data from wearables, cellphones, and linked medical items, Thryve facilitates improved therapy adherence, efficacy, and result measurability.